Works matching AU Kraft, Andrew S.

Results: 27

Phase I dose escalation study of vinorelbine and topotecancombination chemotherapy in patients with recurrent lung cancer.

Published in:

BMC Cancer, 2007, v. 7, p. 231, doi. 10.1186/1471-2407-7-231

By:

Beldner, Matthew A.;
Sherman, Carol A.;
Green, Mark R.;
Garrett-Mayer, Elizabeth;
Chaudhary, Uzair;
Meyer, Mario L.;
Kraft, Andrew S.;
Montero, Alberto J.

Publication type:

Article

The 2014 Surgeon General's report: 'The Health Consequences of Smoking-50 Years of Progress': A paradigm shift in cancer care.

Published in:

2014

By:

Warren, Graham W.;
Alberg, Anthony J.;
Kraft, Andrew S.;
Cummings, K. Michael

Publication type:

Editorial

Treatment of human prostate cancer cells with dolastatin 10, a peptide isolated from a marine shell-less mollusc.

Published in:

Prostate, 1998, v. 34, n. 3, p. 175, doi. 10.1002/(SICI)1097-0045(19980215)34:3<175::AID-PROS4>3.0.CO;2-H

By:

Turner, Timothy;
Jackson, William H.;
Pettit, George R.;
Wells, Alan;
Kraft, Andrew S.

Publication type:

Article

Differentiation of HL-60 cells is associated with an increase in the 35-kDa protein lipocortin I.

Published in:

Journal of Cellular Physiology, 1988, v. 137, n. 3, p. 402, doi. 10.1002/jcp.1041370303

By:

William, Felicia;
Mroczkowski, Barbara;
Cohen, Stanley;
Kraft, Andrew S.

Publication type:

Article

Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation.

Published in:

European Journal of Immunology, 2012, v. 42, n. 4, p. 1044, doi. 10.1002/eji.201040746

By:

Yoshimi, Mayumi;
Goyama, Susumu;
Kawazu, Masahito;
Nakagawa, Masahiro;
Ichikawa, Motoshi;
Imai, Yoichi;
Kumano, Keiki;
Asai, Takashi;
Mulloy, James C.;
Kraft, Andrew S.;
Takahashi, Tsuyoshi;
Shirafuji, Naoki;
Kurokawa, Mineo

Publication type:

Article

Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade.

Published in:

Cancer Biology & Therapy, 2011, v. 12, n. 2, p. 119, doi. 10.4161/cbt.12.2.15723

By:

Kraft, Andrew S.;
Garrett-Mayer, Elizabeth;
Wahlquist, Amy E.;
Golshayan, Ali;
Chien-Shing Chen;
Butler, William;
Bearden, James;
Lilly, Michael

Publication type:

Article

A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomasPresented, in part, at the 39th Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois, May 31June 3, 2003 (abstract 3291).

Published in:

Cancer (0008543X), 2005, v. 103, n. 7, p. 1431

By:

Robert G. Maki;
Andrew S. Kraft;
Kelly Scheu;
Jennifer Yamada;
Scott Wadler;
Cristina R. Antonescu;
John J. Wright;
Gary K. Schwartz

Publication type:

Article

The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling.

Published in:

Molecular & Cellular Biology, 2014, v. 34, n. 13, p. 2517, doi. 10.1128/MCB.00147-14

By:

Bo Cen;
Ying Xiong;
Song, Jin H.;
Mahajan, Sandeep;
DuPont, Rachel;
McEachern, Kristen;
DeAngelo, Daniel J.;
Cortes, Jorge E.;
Minden, Mark D.;
Ebens, Allen;
Mims, Alice;
LaRue, Amanda C.;
Kraft, Andrew S.

Publication type:

Article

EDC3 phosphorylation regulates growth and invasion through controlling P‐body formation and dynamics.

Published in:

EMBO Reports, 2021, v. 22, n. 4, p. 1, doi. 10.15252/embr.202050835

By:

Bearss, Jeremiah J;
Padi, Sathish KR;
Singh, Neha;
Cardo‐Vila, Marina;
Song, Jin H;
Mouneimne, Ghassan;
Fernandes, Nikita;
Li, Yang;
Harter, Matthew R;
Gard, Jaime MC;
Cress, Anne E;
Peti, Wolfgang;
Nelson, Andrew DL;
Buchan, J Ross;
Kraft, Andrew S;
Okumura, Koichi

Publication type:

Article

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells.

Published in:

Oncogene, 2002, v. 21, n. 7, p. 1135, doi. 10.1038/sj.onc.1205151

By:

Nesterov, Alexandre;
Ivashchenko, Yuri;
Kraft, Andrew S.

Publication type:

Article

Regulation of myeloid cell growth by distinct effectors of Ras.

Published in:

Oncogene, 1998, v. 17, n. 21, p. 2701, doi. 10.1038/sj.onc.1202201

By:

Matsuguchi, Tetsuya;
Kraft, Andrew S

Publication type:

Article

Targeted glycoprotein enrichment and identification in stromal cell secretomes using azido sugar metabolic labeling.

Published in:

Proteomics - Clinical Applications, 2013, v. 7, n. 5/6, p. 367, doi. 10.1002/prca.201300006

By:

Roper, Stephen M.;
Zemskova, Marina;
Neely, Benjamin A.;
Martin, Arch;
Gao, Peng;
Jones, E. Ellen;
Kraft, Andrew S.;
Drake, Richard R.

Publication type:

Article

Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report.

Published in:

2021

By:

McBride, Ali;
Garcia, Andrew J;
Sanders, Lauren J;
Yiu, Kelly;
Cranmer, Lee D;
Kuo, Phillip H;
Kay, Matthew;
Kraft, Andrew S

Publication type:

journal article

OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.

Published in:

2022

By:

Thiebaud, Julio Alvarenga;
Ravi, Vinod;
Litwin, Samuel;
Schuetze, Scott M.;
Movva, Sujana;
Agulnik, Mark;
Kraft, Andrew S.;
Tetzlaff, Eric D.;
Somaiah, Neeta;
von Mehren, Margaret

Publication type:

journal article

A randomized, open‐label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft‐tissue sarcoma.

Published in:

Cancer (0008543X), 2021, v. 127, n. 6, p. 894, doi. 10.1002/cncr.33216

By:

Somaiah, Neeta;
Van Tine, Brian Andrew;
Wahlquist, Amy E.;
Milhem, Mohammed M.;
Hill, Elizabeth G.;
Garrett‐Mayer, Elizabeth;
Armeson, Kent E.;
Schuetze, Scott M.;
Meyer, Christian F.;
Reuben, Daniel Y.;
Elias, Anthony D.;
Read, William L.;
Chawla, Sant P.;
Kraft, Andrew S.

Publication type:

Article

AML1/RUNX1 Phosphorylation by Cyclin-Dependent Kinases Regulates the Degradation of AML1/RUNX1 by the Anaphase-Promoting Complex.

Published in:

Molecular & Cellular Biology, 2006, v. 26, n. 20, p. 7, doi. 10.1128/MCB.00597-06

By:

Biggs, Joseph R.;
Peterson, Luke F.;
Youhong Zhang;
Kraft, Andrew S.;
Dong-Er Zhang

Publication type:

Article

PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.

Published in:

2018

By:

Daenthanasanmak, Anusara;
Yongxia Wu;
Iamsawat, Supinya;
Nguyen, Hung D.;
Bastian, David;
MengMeng Zhang;
Sofi, M. Hanief;
Chatterjee, Shilpak;
Hill, Elizabeth G.;
Mehrotra, Shikhar;
Kraft, Andrew S.;
Xue-Zhong Yu;
Wu, Yongxia;
Zhang, MengMeng;
Yu, Xue-Zhong

Publication type:

journal article

Regulation of AP-3 enhancer activity during hematopoietic differentiation.

Published in:

Journal of Cellular Physiology, 1995, v. 164, n. 1, p. 26, doi. 10.1002/jcp.1041640105

By:

Adler, Victor;
Kraft, Andrew S.

Publication type:

Article

Induction of differentiation and c-jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatases.

Published in:

Journal of Cellular Physiology, 1992, v. 151, n. 2, p. 415, doi. 10.1002/jcp.1041510223

By:

Adunyah, Samuel E.;
Unlap, Tino M.;
Franklin, Christopher C.;
Kraft, Andrew S.

Publication type:

Article

PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.

Published in:

Journal of Cell Biology, 2023, v. 222, n. 6, p. 1, doi. 10.1083/jcb.202208136

By:

Jensen, Corbin C.;
Clements, Amber N.;
Liou, Hope;
Ball, Lauren E.;
Bethard, Jennifer R.;
Langlais, Paul R.;
Toth, Rachel K.;
Chauhan, Shailender S.;
Casillas, Andrea L.;
Daulat, Sohail R.;
Kraft, Andrew S.;
Cress, Anne E.;
Miranti, Cindy K.;
Mouneimne, Ghassan;
Rogers, Greg C.;
Warfel, Noel A.

Publication type:

Article

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.

Published in:

Oncogene, 2003, v. 22, n. 32, p. 4953, doi. 10.1038/sj.onc.1206656

By:

Johnson, Thomas R;
Stone, Kimberley;
Nikrad, Malti;
Yeh, Tammie;
Zong, Wei-Xing;
Thompson, Craig B;
Nesterov, Alexandre;
Kraft, Andrew S

Publication type:

Article

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.

Published in:

Cell Death & Differentiation, 1999, v. 6, n. 2, p. 175, doi. 10.1038/sj.cdd.4400477

By:

Hedlund, Tammy E;
Meech, Sandra J;
Srikanth, Sampathkumar;
Kraft, Andrew S;
Miller, Gary J;
Schaack, Jerome B;
Duke, Richard C

Publication type:

Article

Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.

Published in:

Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-12

By:

An, Ningfei;
Kraft, Andrew S.;
Yubin Kang

Publication type:

Article

An XBP1s–PIM-2 positive feedback loop controls IL-15–mediated survival of natural killer cells.

Published in:

Science Immunology, 2023, v. 8, n. 81, p. 1, doi. 10.1126/sciimmunol.abn7993

By:

Ma, Shoubao;
Han, Jingjing;
Li, Zhenlong;
Xiao, Sai;
Zhang, Jianying;
Yan, Jiazhuo;
Tang, Tingting;
Barr, Tasha;
Kraft, Andrew S.;
Caligiuri, Michael A.;
Yu, Jianhua

Publication type:

Article

Pim1 Serine/Threonine Kinase Regulates the Number and Functions of Murine Hematopoietic Stem Cells.

Published in:

Stem Cells, 2013, v. 31, n. 6, p. 1202, doi. 10.1002/stem.1369

By:

An, Ningfei;
Lin, Ying-Wei;
Mahajan, Sandeep;
Kellner, Joshua N.;
Wang, Yong;
Li, Zihai;
Kraft, Andrew S.;
Kang, Yubin

Publication type:

Article

Bryostatin 1: will the oceans provide a cancer cure?

Published in:

1993

By:

Kraft, Andrew S.;
Kraft, A S

Publication type:

commentary

PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.

Published in:

Molecular Oncology, 2020, v. 14, n. 5, p. 974, doi. 10.1002/1878-0261.12662

By:

Singh, Neha;
Padi, Sathish K. R.;
Bearss, Jeremiah J.;
Pandey, Ritu;
Okumura, Koichi;
Beltran, Himisha;
Song, Jin H.;
Kraft, Andrew S.;
Olive, Virginie

Publication type:

Article